Rapid Gas Chromatographic Method for Quantitation of Ethchlorvynol ("Placidyl
added to serum was 87%. Subsequently, all standards were prepared in serum, to compensate for the nonquantitative yield and to help assure accuracy. Sera from healthy controls and from hospitalized patients contain no endogenous interfering substances, nor did any of a series of commonly prescribed drugs interfere.
Since introduced in 1955, ethchlorvynol (1-chloro-3-ethyl-1-penten-4-yn-3-ol;
"Placidyl"; Abbott Laboratories, North Chicago, Ill. 60064) has been a widely used synthetic hypnotic. Reports of ethchlorvynol abuse resulting in intoxication, addiction, or death have been well documented (1) (2) (3) (4) .
Several analytical methods for the quantitation of ethchlorvynol in biological materials have been previously developed. Algeri et al. (1) introduced a colorimetric method in 1962 that involved production of a red or yellow color when the allyl group of ethchlorvynol reacted with phloroglucinol.
Because the separation was not spe- 
Materials and Methods

Reagents
Apparatus
The gas chromatograph used throughout this study was a F&M Model 402B (Hewlett-Packard, Avondale, Pa. 19311) equipped with dual hydrogen flame-ionization detectors, a solid state ac line operated electrometer, and a H10-7127A strip-chart recorder. A U-shaped glass column (150 cm long, 1.5 mm i.d.) was packed with "Chromosorb 101," 80/ 100 mesh (Anspec Co.). Flow rates were 30, 20, and 380 mi/mm for helium, hydrogen, and air, respectively. Operating temperatures were: column, 245 #{176}C; injection port, 320 #{176}C; and flame detector, 325 #{176}C. The electrometer was operated in a single-channel mode, with settings of range x 10 and attenuation x4. Recorder speed was 1.27 cm/mm.
For the colorimetric procedure we used a "Spectronic 505" double-beam recording ultraviolet-visible spectrophotometer (Bausch & Lomb, Inc., Rochester, N. V. 14602).
Procedures
Gas-chromatographic method.
Pipet 2.0 ml of serum into a 16 x 100 mm glass test tube containing 1 g of calcium sulfate ("Drierite").
Add 0.50 ml of The method of Andryauskis et al. (6) was applied to a sodium tungstate-sulfuric acid filtrate of serum for purposes of comparison with the GC method. The absorbance, at 510 nm, of the red chromogen was measured vs. a reagent blank with the recording spectrophotometer. We (Figure 1) . Ether, which is highly volatile, can be used as the extractant only when the internal standard is routinely used, because the ratio of the drug to dodecane in both the standard and the sample will remain constant, even if the solvent evaporates.
To low response from the flame ionization detector. Subsequently, the high volatility of ether concentrated the sample during the extraction and centrifugation steps, which increased the sensitivity of the procedure.
As mentioned before, the internal standard compensated for the solvent loss, so accurate results could easily be obtained.
An initial volume of 0.50 ml of ether yielded an adequate residual solvent volume for GC analysis. "Drierite" was added to the extraction mixture to prevent formation of an emulsion.
To study the effect of sample size on linearity and sensitivity, we extracted 0.5, 1.0, 2.0, and 3.0 ml of serum standards containing ethchlorvynol at concentrations ranging from 5 to 200 mg/liter (plus 0.50 ml of the internal standard) with 0.50 ml of ether. Leastsquares plots of peak height ratios vs. concentration for the various sample sizes are shown in Figure 2 . The least-squares lines increase linearly with increasing sample size, producing slopes of 0.021, 0.041, 0.081, and 0.125 for the 0.5-, 1.0-, 2.0-, and 3.0-ml samples, respectively. The y intercepts are <0.08 in all cases. The data indicate that a 2-mi sample is an optimal combination for adequate sensitivity and small sample size. Smaller samples result in reduced sensitivity, larger samples result in a larger standard deviation, as evidenced by the increased scatter about the least-squares line for the 3-mi sample.
We tested the completeness of extraction by varying the time of mechanical mixing from 30 s to 4 mm, using 2 ml of serum and 0.5 ml of ether. The percent of ethchlorvynol extracted was calculated by comparison with the direct injection of an ether standard into the gas chromatograph.
With duplicate samples of 10 mg/liter for each time interval, the percent extracted increased slightly from 76% at 30 s to 87% at 1.5 mm and remained constant for all longer times studied. We recommend a mixing time of 2.0 mm.
The "Drierite" prevents a thick, gelatinous emulsion from forming during the ether extraction. When this occurs, there is no ether layer to sample and GC analysis is impossible. Usual emulsion-breaking techniques were ineffective. Varying pH, by adding NaOH or HC1 (each 0.5 mol/liter) to the serum, did not affect the percent extracted in a pH range of 6 thru 12. At a pH of less than 6, even with "Drierite," a solid plug formed in the upper part of the tube that normally contained the ether layer, leaving no ether available for GC analysis.
The pH of the extraction mixture with "Drierite" was 7.0. Hence, we concluded that we should use "Drierite" and should not adjust the pH of the mixture before its extraction.
Precision.
We measured the precision of the instrument and the injection step (without extraction) by injecting, 10 consecutive times, 1 A1 of a standard ether solution containing, per liter, 50 mg each of ethchlorvynol and dodecane. The SD was 0.19 mg/ liter, the CV 0.38%.
Within-run precision of the method was determined by extracting and injecting a 10 mg/liter standard of ethchlorvynol in serum 10 consecutive times. The SD was 0.37 mg/liter, CV 3.7%.
Day-to-day precision was assessed by analyzing for 20 consecutive days a serum pool to which ethchlorvynol had been added. The mean was 15.01 (SD, 0.85 mg/liter; CV, 5.6%). The above precision studies indicate the method is adequate for routine drug analyses.
Accuracy of the Method
Recovery.
Ethchlorvynol was added to three pools of drug-free serum in concentrations of 4, 22, and 60 mg/liter, and then analyzed in triplicate. By comparison with ether standards, it was found that 83% to 90% of ethchlorvynol could be extracted from serum (mean, 87%) by a one-stage ether extraction. Attempts at salting-out by saturating with sodium acetate, sodium chloride, potassium chloride, potassium nitrate, and sodium carbonate did not increase the percent of ethchlorvynol extracted.
The extraction of aqueous ethchlorvynol standards was 20% lower than the extraction of serum ethchlorvynol standards.
Hence, we conclude that analytical standards must be prepared in serum. Recovery studies of individual serum samples were all within the range of the pools studied above. Therefore, recovery of added drug is evidently relatively constant from sample to sample.
Comparisons.
Ethchlorvynol was added to 30 drug-free sera to yield final concentrations of about 4 to 113 mg/liter.
Single determinations were performed on each sample by both the GC method and the method of Andryauskis et al. (6) . Table 1 gives the least-squares statistics for the comparison study. Ideally, of course, the slope should be 1.000 and both the x and y intercepts should be zero. In this case, a very small proportional error of about 1.1% was indicated by the slope of 0.989. The y-intercept reflected a constant error of 0.09 mg/liter which, for our purposes, is insignificant.
Random error, as reflected by both the standard error of estimate in the y direction (Sr) and the standard deviation of differences (SDd) was ±5.1 mg/liter at a 95% confidence level, a random error well within clinical laboratory requirements. The bias and t value were small, but cannot be precisely interpreted as measures of constant error because of the presence of the 1.1% proportional error (13) . The plotted points had a relatively even distribution within the concentration range considered and no individual sample that deviated significantly from the others. The correlation coeffi- Each of the samples was taken through the proposed procedure and analyzed on the gas chromatograph.
No extraneous peaks appeared on the strip-chart recording of the chromatogram. We conclude that such abnormal concentrations do not introduce interferences into the analytical procedure. These same sera were analyzed after the addition of a known amount of ethchlorvynol. Recovery obtained by the GC method agreed with the calculated concentrations within ±2.7% at a 95% confidence level. This indicates that the recovery of added drug from normal or pathological serum is the same.
Some drugs that might be taken concomitantly with ethchlorvynol were added to drug-free serum pools and analyzed by the GC method. None of the following drugs produced an interfering peak: diazepam ("Valium"), nordiazepam, primidone ("Mysolmne"), and "diphenylhydantomn ("Dilantin"), each at 600 mg/liter; cocaine, codeine, methadone, and morphine, each at 8 mg/liter; amobarbital, secobarbital, pentobarbital, phenobarbital, glutethimide ("Doriden"), and salicylate, each at 600 mg/liter; methaqualone, methapyrilene, qumnidmne, methyprylon ("Noludar"), glutethimide ("Doriden"), meprobamate ("Miltown"), each at 10 mg/liter; amphetamine and methamphetamine each at 40 mg/ liter; propoxyphene ("Darvon"), 70 mg/liter; diphenhydramine ("Benadryl"), meperidine ("Demerol"), aminophylline, each at 80 mg/liter; chlordiazepoxide ("Librium"), 90 mg/liter, acetaminophen ("Tylenol"), imipramine ("Tofranil"), chlorpromazine ("Thorazine"), thioridazine ("Mellaril"), prochlorperazine ("Compazine"), trifluoperazine ("Stelazine"), promazine ("Sparine"), nortryptyline ("Aventyl"), desipramine ("Norpramin"), each at 100 mg/ liter; caffeine, 130 mg/liter; pentazocine ("Talwin"), 150 mg/liter; salicylamide, 180 mg/liter; and phenazopyridine ("Pyridium"), 250 mg/liter. Recovery studies were also conducted in the presence of the above drugs. Known amounts of ethchlorvynol were added to each pool. The results of the recovery of ethchlorvynol agreed with known concentrations within ±2.2% at a 95% confidence level. We conclude that these drugs do not interfere with recovery of added ethchlorvynol.
Discussion
The method described will rapidly identify and quantitate ethchlorvynol in human serum with excellent accuracy and precision. Analysis of a single sample requires only about 20 mm, making it less time-consuming than most previously published methods and in many cases requiring less manipulation (1-2, 5-8, [10] [11] [12] . The excellent correlation with the colorimetric method is demonstrated by the data shown in Table 1 . This method is applicable to routine and emergency laboratory determinations of ethchlorvynol.
A 2-ml sample of serum is recommended for optimum sensitivity but smaller samples may be analyzed, if necessary, with slightly decreased precision owing to a decreased sensitivity.
The linear range (up to 200 mg/liter) for this procedure is adequate for nearly all overdose cases that may be encountered.
The method is also sensitive enough to determine therapeutic serum concentrations (0.2-5 mg/liter).
For 2 ml of serum and a injection of ether extract at range xlO and attenuation x2, the detection limit (defined as signal twice the baseline noise level) was 0.2 mg/liter. According to Winek (14) , therapeutic levels are near 5 mg/liter and toxic levels are those greater than 20 mg/liter; 138 mg/liter may be fatal (1) .
Of the exogenous substances we tested, only phenazopyridine produced a peak on the gas chromatograph. At a concentration of 250 mg/liter, the phenazopyridine peak height was about 1 cm and had a relative retention time of 0.77, as compared with 0.67 for ethchlorvynol.
Because the retention times differ and the GC is so insensitive to phenazopyridine, it does not interfere with this analytical method. Our GC method has been used successfully in the routine service laboratory for about five months. The laboratory operates on a 24-hour-a-day, seven-day-a-week schedule.
